Research Article

Correlation of Serum Cardiac Markers with Acute Decompensating Events in Liver Cirrhosis

Table 2

Comparison of characteristics of cirrhotic patients with ascites, acute gastrointestinal hemorrhage, ACLF, and without decompensating events.

VariablesWith ascitesWith acute gastrointestinal hemorrhageWith ACLF
No. Pts; median (range) or frequency (percentage) valueNo. Pts; median (range) or frequency (percentage) valueNo. Pts; median (range) or frequency (percentage) value

Sex (male/female), (%)9664 (66.67%)/32 (33.33%)0.0648656 (65.12%)/30 (34.88%)0.039108 (80%)/2 (20%)0.558
Age (years)96; 60.00 (48.00-65.75)0.02786; 54.00 (45.00-63.25)0.69210; 48.00 (45.00-57.00)0.429
Red blood cell (1012/L)96; 3.08 (2.57-3.83)<0.00186; 2.75 (2.39-3.35)<0.00110; 2.60 (1.78-3.45)<0.001
Hemoglobin (g/L)96; 93.00 (70.00-113.75)<0.00186; 76.00 (66.00-99.00)<0.00110; 98.50 (65.25-117.25)0.018
Hematocrit (%)96; 28.40 (21.38-34.33)<0.00186; 23.15 (20.33-30.20)<0.00110; 28.80 (18.58-34.75)0.004
White blood cell (109/L)96; 3.85 (2.73-6.18)0.11986; 3.60 (2.38-6.30)0.39010; 6.15 (4.43-8.25)0.021
Platelet count (109/L)96; 78.00 (54.00-106.75)0.38486; 72.50 (51.00-103.75)0.75510; 64.50 (39.00-97.25)0.562
Total bilirubin (μmol/L)96; 28.90 (15.38-63.15)0.18686; 19.55 (13.20-32.20)0.29210; 166.20 (121.25-223.50)<0.001
Direct bilirubin (μmol/L)96; 13.45 (6.43-37.53)0.03986; 8.45 (5.40-16.23)0.58210; 105.10 (82.08-184.23)<0.001
Alanine aminotransferase (U/L)96; 23.09 (16.25-39.37)0.51786; 20.92 (14.62-36.63)0.13210; 51.43 (23.77-63.76)0.012
Aspartate aminotransferase (U/L)96; 34.56 (24.01-68.95)0.40486; 27.45 (20.43-48.41)0.23210; 93.55 (65.65-128.31)<0.001
Alkaline phosphatase (U/L)96;
101.99 (75.12-149.67)
0.62186; 81.09 (59.99-110.37)0.01910; 137.08 (84.14-169.98)0.202
Gamma-glutamyl transpeptidase (U/L)96; 46.21 (21.10-108.21)0.90186; 29.01 (16.74-57.98)0.03210; 67.05 (37.05-97.91)0.218
Albumin (g/L)96; 29.65 (25.10-33.40)<0.00186; 31.10 (25.68-36.18)<0.00110; 22.80 (19.95-26.98)<0.001
Blood urea nitrogen (mmol/L)96; 6.05 (4.42-7.86)0.00786; 6.25 (4.39-8.46)0.00310; 6.26 (4.78-11.15)0.070
Creatinine (μmol/L)96; 63.55 (53.23-82.68)0.68686; 65.86 (52.78-75.94)0.89510; 61.15 (52.53-101.95)0.763
eGFR (mL/min/1.73 m2)96; 104.38 (77.60-133.84)0.04786; 108.07 (86.83-138.32)0.24710; 107.84 (73.24-137.83)0.403
Na (mmol/L)96; 137.75 (134.93-140.95)0.04186; 139.35 (136.55-141.03)0.74110; 135.20 (131.55-139.15)0.021
Prothrombin time (second)96; 17.15 (15.60-20.45)0.00186; 16.90 (15.20-19.10)0.02610; 22.85 (20.65-27.95)<0.001
Activated partial thromboplastin time (second)96; 41.90 (37.73-47.28)0.98786; 39.70 (36.98-43.98)0.06410; 52.85 (46.63-55.95)<0.001
International normalized ratio96; 1.40 (1.25-1.75)0.00186; 1.37 (1.21-1.60)0.03110; 1.99 (1.77-2.59)<0.001
D-dimer (mg/L)95; 2.28 (0.93-4.64)<0.00183; 1.43 (0.58-3.57)0.0019; 4.51 (3.41-9.02)<0.001
High-sensitivity C-reactive protein (mg/L)95; 6.90 (2.20-20.30)0.00185; 4.50 (1.20-11.55)0.07110; 30.65 (11.35-75.35)<0.001
MELD score96; 13.50 (10.07-18.23)0.00186; 10.65 (9.13-14.42)0.34310; 28.14 (21.24-30.04)<0.001
Child-Pugh score96; 8.00 (7.00-10.00)<0.00186; 7.00 (6.00-8.00)<0.00110; 12.00 (11.75-13.00)<0.001
NT-pro BNP (pg/mL)87; 165.20 (71.06-415.80)<0.00178; 144.95 (60.82-443.93)<0.00110; 212.30 (150.70-1662.75)<0.001
High-sensitivity cardiac troponin T (ng/mL)92; 0.008 (0.005-0.014)0.00281; 0.009 (0.005-0.014)0.0039; 0.007 (0.005-0.035)0.157
Creatine kinase (U/L)95; 69.00 (45.00-97.00)0.09984; 69.00 (40.50-105.50)0.11710; 71.50 (41.25-109.00)0.501
Creatine kinase MB (U/L)95; 29.00 (20.00-42.00)0.46384; 29.50 (19.00-43.75)0.55210; 22.50 (14.50-36.00)0.163
Lactate dehydrogenase (U/L)95; 195.00 (154.00-232.00)0.07684; 171.00 (140.00-206.25)0.72710; 235.00 (157.50-317.25)0.050

Bold font indicates statistically significant values. Abbreviations: ACLF: acute-on-chronic liver failure; eGFR: the estimated glomerular filtration rate; MELD: model for end-stage liver disease; NT-pro BNP: N-Terminal pro-B-type natriuretic peptide.